Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies

An emerging body of evidence has implicated plasminogen activator inhibitor-1 (PAI-1) in the development of type 2 diabetes (T2D), though findings have not always been consistent. We systematically reviewed epidemiological studies examining the association of PAI-1 with T2D. EMBASE, PubMed, Web of S...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarmolinsky, James, Bordin Barbieri, Natália, Weinmann, Tobias, Ziegelmann, Patricia K., Duncan, Bruce B., Inês Schmidt, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728395/
https://www.ncbi.nlm.nih.gov/pubmed/26813008
http://dx.doi.org/10.1038/srep17714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728395/
https://www.ncbi.nlm.nih.gov/pubmed/26813008
http://dx.doi.org/10.1038/srep17714

Ejemplares similares